Page 28 - Divis Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On a consolidated basis, Divi's Laboratories reported 31.1% jump in net profit to Rs 470.62 crore on a 21.9% rise in net sales to Rs 1701.44 crore in Q3 FY21 over Q3 FY20. The company reported a forex gain of Rs 2.53 crore in the quarter ended December 2020 as against a forex gain of Rs 17.96 crore in the quarter ended December 2019. Profit before tax in Q3 December 2020 stood at Rs 642.08 crore, up by 31.8% from Rs 487.32 crore in Q3 December 2019. Current tax expenses during the quarter increased by 18.4% year-on-year (YoY) to Rs 144.78 crore. "The company has been able to have normalized ...

Taking Stock | Budget rally continues as benchmark index scales record high Broader markets outperformed the main indices with BSE Midcap and Smallcap indices rose over 1 percent each. February 03, 2021 / 04:25 PM IST The Budget exuberance continued on the Dalal Street on the third consecutive day on February 3 with benchmark indices hitting record levels, also helped by the positive global cues. At close, the Sensex was up 458.03 points or 0.92% at 50,255.75, and the Nifty was up 142.10 points or 0.97% at 14,790. "We have been successful in getting past 14,753.55 which was the previous h...

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls Premium (REUTERS) Ronojoy Mazumdar , Bloomberg Overall in absolute terms, analysts’ average 12-month target price for Divi’s stock has risen about ₹134 in the past four weeks Share Via Some analysts are turning even more bullish on India’s best-performing large-cap stock in 2020. In just about two weeks, at least four brokerages have raised their price targets on Divi’s Laboratories Ltd., one of the top producers of active pharmaceutical ingredients, with Jefferies India Pvt.’s estimate -- which ta...

S&P BSE Sensex edged 139 points or 0.3% higher to end at 46,099 and the 50-scrip NSE Nifty was at 13,514 levels, up by almost 36 points or 0.26%